These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1627988

  • 1. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
    Makela EH, Cutlip WD.
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):234-5. PubMed ID: 1627988
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G, Liss C, Reines S, Irr J, Nibbelink D.
    Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028
    [Abstract] [Full Text] [Related]

  • 3. Comparative multiple-dose pharmacokinetics of controlled-release levodopa products.
    Grahnén A, Eckernäs SA, Collin C, Ling-Andersson A, Tiger G, Nilsson M.
    Eur Neurol; 1992; 32(6):343-8. PubMed ID: 1490503
    [Abstract] [Full Text] [Related]

  • 4. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC, Horstink MW, Roos RA, Jansen EN.
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract] [Full Text] [Related]

  • 5. Sinemet CR in Parkinson's disease.
    Pfeiffer RF, Wilken KE, Glaeske CS, Hofman R.
    Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
    [Abstract] [Full Text] [Related]

  • 6. Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.
    LeWitt PA, Nelson MV, Berchou RC, Galloway MP, Kesaree N, Kareti D, Schlick P.
    Neurology; 1989 Nov; 39(11 Suppl 2):45-53; discussion 59. PubMed ID: 2685650
    [Abstract] [Full Text] [Related]

  • 7. Treatment of early Parkinson's disease with controlled-release levodopa preparations.
    Rinne UK, Rinne JO.
    Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766
    [Abstract] [Full Text] [Related]

  • 8. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease.
    Feldman RG, Mosbach PA, Kelly MR, Thomas CA, Saint Hilaire MH.
    Neurology; 1989 Nov; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.
    Benetello P, Furlanut M, Zara G, Baraldo M, Hassan E.
    Eur Neurol; 1993 Nov; 33(1):69-73. PubMed ID: 8440292
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study.
    Sage JI, Mark MH.
    Clin Neuropharmacol; 1988 Apr; 11(2):174-9. PubMed ID: 3378226
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB, Suchowersky O, Purves S, Calne S, Calne DB.
    Clin Neuropharmacol; 1986 Apr; 9(2):196-9. PubMed ID: 3708604
    [No Abstract] [Full Text] [Related]

  • 18. The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease.
    Roos RA, Tijssen MA, van der Velde EA, Breimer DD.
    Clin Neurol Neurosurg; 1993 Sep; 95(3):215-9. PubMed ID: 8242964
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
    Yeh KC, August TF, Bush DF, Lasseter KC, Musson DG, Schwartz S, Smith ME, Titus DC.
    Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.